Fairvalue-Calculator Fairvalue-Calculator
EN DE

China Health Technology Group (CHBOF) Fair Value & Analysis

Basic Materials · US · Market cap $4.0M

Price$0.0330
Fair Value$0.0377
Upside+14.2%
Quality95/100
Evidence: High Range $0.0318 – $0.0844

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

China Health Technology Group (CHBOF) currently trades at $0.0330, while our model-based Fair Value estimate is $0.0377 — implying the stock looks roughly 14.2% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

China Health Technology Group Holding Company Limited, an investment holding company, engages in the forestry management business in the People's Republic of China. The company operates through Forestry Business, Ginseng Business, and Horny Goat Weed Business segments. The Forestry Business segment engages in the plantation, logging, and sale of timber related products. The Ginseng Business segment is involved in the ginseng plantation and trading of related products. The Horny Goat Weed Business segment engages in the horny goat weed plantation and trading of related products. The company was formerly known as China Bozza Development Holdings Limited and changed its name to China Health Technology Group Holding Company Limited in December 2023. China Health Technology Group Holding Company Limited was incorporated in 2009 and is headquartered in Shenzhen, China.

Open the full interactive analysis →

Similar stocks

Simpson Manufacturing Co (SSD) -43% West Fraser Timber Co (WFG) -89% UFP Industries, Inc (UFPI) -6% Stella-Jones Inc (STLJF) +16% Boise Cascade Company (BCC) -37% DeHua TB New Decoration Material Co (002043) +22%

Frequently asked questions

Is China Health Technology Group (CHBOF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0377 versus a price of $0.0330 — about +14% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CHBOF?
Our 21-model fair value for China Health Technology Group is $0.0377 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0330.
What is the quality score of CHBOF?
China Health Technology Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.